Home / Ingredients / Curcumin

Ingredient Evidence Summary

Curcumin

Evidence summary for inflammation support, joint comfort, and bioavailability considerations.

Evidence grade B Aliases: turmeric extract, curcuminoids

Quick answer

Curcumin is one of the clearest ingredient-level entities in your catalog and should exist as a standalone research page independent of product merchandising.

V-CURCUMAX combines pharmaceutical-grade curcumin (95% curcuminoids) with absorption-enhancing piperine and synergistic Boswellia extract to deliver clinically meaningful anti-inflammatory and joint-supportive effects. The piperine component increases curcumin bioavailability by up to 2000%, addressing curcumin's well-documented absorption limitation. This formulation is best suited for individuals managing chronic inflammatory conditions such as osteoarthritis, rheumatoid arthritis, or exercise

Mechanism

Curcumin modulates NF-kB, COX-2, and other inflammatory pathways, while piperine increases bioavailability by reducing first-pass metabolism.

Dosage context

Your repository centers on clinically relevant curcumin doses paired with piperine to improve absorption.

Common questions this page is built to answer

Related product research

PubMed-backed citations used in the current corpus

Primary source page in your current corpus: V-CURCUMAX.